SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000946644-14-000012
Filing Date
2014-07-10
Accepted
2014-07-10 16:01:03
Documents
3
Period of Report
2014-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjuly32014execbonusesby.htm 8-K 23106
2 AMENDED AND RESTATED BY-LAWS a31amendedandrestatedby-la.htm EX-3.1 106837
3 ADAM PASCALE EMPLOYMENT AGREEMENT a101adampascaleemploymenta.htm EX-10.1 33551
  Complete submission text file 0000946644-14-000012.txt   164934
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 14969657
SIC: 2836 Biological Products, (No Diagnostic Substances)